Immunocore – FDA Approved Treatment for Metastatic Uveal Melanoma
David Berman, Head of Research and Development at Immunocore discusses the 3-year overall survival data from the KIMMTRAK Phase 3 trial that was pre...
293 articles
David Berman, Head of Research and Development at Immunocore discusses the 3-year overall survival data from the KIMMTRAK Phase 3 trial that was pre...
Arlene Siefker-Radtke, Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer ...
Kim Chi, Senior Research Scientist, Vancouver Prostate Centre discusses his presentation at ESMO 2023, abstract #LBA85 - Niraparib (NIRA) with abiratero...
Meredith Huetter, a stage lll colorectal cancer survivor, shares her personal story of learning she had CRC and how her treatment journey has gone thus ...
Steven Quay, Chairman of the Board and CEO of Atossa Therapeutics, a company focused on preventing breast cancer in at-risk women and treating breast ca...
Arun Krishna, VP, Head of Lung Cancer Franchise, US Oncology Business Unit at AstraZeneca discusses the positive results from the FLAURA2 Phase III tria...
Paul Limburg, Chief Medical Officer, Screening at Exact Sciences discusses recent research that revealed countless reasons why 45-year-olds in the U.S.
Erin Crane, MD, MPH, gynecologic oncologist with the Atrium Health Levine Cancer Institute and Bobbie, an ovarian cancer patient discuss the prevalenc...
Jeremy Abramson, Director of the Lymphoma Program and the Jon and Jo Ann Hagler Chair in Lymphoma at the Massachusetts General Hospital Cancer Center an...
Returning guest, Sylvie Beljanski, Founder and Executive Vice President of the Beljanski Foundation and a renowned expert in the field of natural approa...